Asimov

Business Development Manager

United Kingdom

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Synthetic BiologyIndustries

Business Development Manager - Europe

Employment Type: Full-time

Position Overview

Asimov is seeking a proactive and results-driven Business Development Manager for Europe to join our rapidly growing Commercial Team. This senior individual contributor role focuses on driving new business within the territory, nurturing relationships with existing partners, and increasing market awareness of Asimov. The successful candidate will demonstrate leadership, autonomy, and strategic ownership, collaborating across teams to achieve collective goals and make an immediate impact on Asimov’s commercial growth and strategy.

About the Role

  • Drive Revenue Growth: Develop and execute territory expansion strategies to source and secure new opportunities, drive revenue, increase market presence, and position Asimov within the broader biopharma ecosystem, in collaboration with colleagues across the Commercial Team.
  • Customer Relationship Development: Build and nurture relationships with clients, ranging from virtual organizations to large drug developers, with a strong focus on customer centricity.
  • Communicate Asimov’s Platform Technologies: Effectively convey the technical and commercial benefits of Asimov's offerings to potential clients.
  • Own the Commercial Deal Process: Shape partnership strategy and collaborate with the broader Commercial Team to develop deal structures that maximize value for all parties involved. Drive alignment on terms, proposals, and agreements to achieve territory and organizational goals.
  • Engage with Industry: Represent Asimov externally at key conferences, meetings, and industry events to raise visibility, build relationships, and strengthen our reputation within the field.
  • Contribute to Our Culture: Further enable our collaborative and open culture by sharing insights, maintaining transparency, and supporting peers.

About You

  • Professional Experience:
    • 4+ years of commercial experience within biotechnology, CDMO/CRO services, or life sciences tools organizations.
    • Complemented by 8 years of overall experience in the biotechnology, bioproduction, or life sciences industries.
  • Deal Development:
    • Track record of selling bespoke technical services, especially where strategy and creativity were key to customer engagement.
    • Ability to navigate complex sales cycles, balancing client priorities with internal capabilities and capacity.
  • Industry Knowledge:
    • A deep understanding of the biotherapeutics manufacturing landscape.
  • Networking Skills:
    • Ability to rapidly build rapport and effectively communicate the benefits of partnering with Asimov.
    • Established and expanding network within the biopharma services and tools market.
  • Customer Relationship Expertise:
    • Demonstrated history of growing long-term relationships with clients.
  • Technical Acumen:
    • In-depth knowledge of cell line development.
    • Deep understanding of CMC, process development, and manufacturing of biologics and/or viral vectors.
  • Educational Background:
    • A scientific or technical background in life sciences (e.g., bioengineering, molecular biology, bioproduction).
    • Advanced degrees (MBA, MS, PhD) are welcome but not required.

Company Information

Asimov's mission is to advance humanity's ability to design living systems, enabling biotechnologies with outsized benefit to society. We are developing a mammalian synthetic biology platform––from cells to software––to enable the design and manufacture of next-generation therapeutics. We are fueled by a vision to transform biological engineering into a fully-fledged engineering discipline. Should you join our team, you will grow with a constantly evolving organization and push the frontiers of synthetic biology. Company culture is key to Asimov, and ours is a culture of recombination; we believe that our mission can only be achieved through diverse perspectives and collaborative innovation.

Skills

Business Development
Sales
Relationship Management
Biopharma
Synthetic Biology
Negotiation
Strategic Planning
Market Awareness

Asimov

Synthetic biology solutions for biopharmaceuticals

About Asimov

Asimov operates in the synthetic biology field, providing a combination of cells, genes, and software to assist in advanced genetic design. Their products include cloud-based software that allows clients in the biopharmaceutical industry to design, simulate, and optimize genetic systems. Additionally, they offer engineered GMP host cells that are used for therapeutic applications. Asimov distinguishes itself from competitors by guaranteeing high titer cell lines for monoclonal antibodies with a promise of '4 g/L or it's free,' which reduces risk for their clients. The company's goal is to enable biopharma companies to produce high-quality protein therapeutics and scalable viral vectors efficiently, supported by their in-house expertise in synthetic biology and process development.

Boston, MassachusettsHeadquarters
2017Year Founded
$199.1MTotal Funding
SERIES_BCompany Stage
AI & Machine Learning, BiotechnologyIndustries
51-200Employees

Risks

Competition from LatchBio's code-free biocomputing infrastructure challenges Asimov's software offerings.
Integration of The Foundry may lead to potential cultural clashes and operational disruptions.
Rapid data generation in synthetic biology may strain Asimov's data processing capabilities.

Differentiation

Asimov offers a '4 g/L or it's free' promise for monoclonal antibodies.
The LV Edge Producer System eliminates GMP plasmid costs and reduces process complexity.
Asimov integrates synthetic biology, computer-aided design, and machine learning for genetic design.

Upsides

Stable cell line development reduces costs and increases scalability in lentiviral production.
Acquisition of The Foundry enhances Asimov's expertise in genetic design and engineering.
Growing biotech investments indicate a robust market for Asimov's engineered cell lines.

Land your dream remote job 3x faster with AI